-
1Academic Journal
Συγγραφείς: G. Ya. Osmanova, V. A. Aleksandrov, A. V. Aleksandrov, L. N. Shilova, E. G. Cherkesova, N. V. Aleksandrova, I. A. Zborovskaya, Г. Я. Османова, В. А. Александров, А. В. Александров, Л. Н. Шилова, Е. Г. Черкесова, Н. В. Александрова, И. А. Зборовская
Συνεισφορές: The authors are grateful to the staff of the Volgograd Center for Diagnostics and Treatment of Osteoporosis (chief Polyakova Yu.V.) for their help in collecting clinical materials, as well as to the staff of the Department of Clinical Laboratory Diagnostics of Volgograd Medical University (chief Zavodovsky B.V.) for methodical assistance in conducting laboratory tests.
Πηγή: Medical Immunology (Russia); Том 26, № 2 (2024); 393-400 ; Медицинская иммунология; Том 26, № 2 (2024); 393-400 ; 2313-741X ; 1563-0625
Θεματικοί όροι: низкотравматичные переломы, angiopoietin-like protein type 4, anti-citrullinated protein antibodies, bone mineral density, osteoporosis, fragility fractures, ангиопоэтин-подобный белок 4-го типа, антитела против циклического цитруллинового пептида, минеральная плотность кости, остеопороз
Περιγραφή αρχείου: application/pdf
Relation: https://www.mimmun.ru/mimmun/article/view/2862/1912; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2862/12469; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2862/12470; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2862/12471; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2862/12472; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2862/12473; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2862/12474; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2862/12475; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2862/12476; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2862/12670; Abdelhafiz D., Baker T., Glascow D.A., Abdelhafiz A. Biomarkers for the diagnosis and treatment of rheumatoid arthritis – a systematic review. Postgrad. Med., 2023, Vol. 135, no. 3, pp. 214-223.; Adami G., Saag K.G. Osteoporosis pathophysiology, epidemiology, and screening in rheumatoid arthritis. Curr. Rheumatol. Rep., 2019, Vol. 21, no. 7, 34. doi:10.1007/s11926-019-0836-7.; Aleksandrov V.A., Shilova L.N., Aleksandrov A.V., Osmanova G.Y., Aleksandrova N.V., Zborovskaya I.A. The decrease in bone mineral density depends on the concentrations of angiopoietin-like protein type 4 in patients with rheumatoid arthritis. Ann. Rheum. Dis., 2021, Vol. 80, no. S1, 225. doi:10.1136/annrheumdis-2021-eular.2266.; D’Onofrio B., di Lernia M., de Stefano L., Bugatti S., Montecucco C., Bogliolo L. Personalized therapeutic strategies in the management of osteoporosis in patients with autoantibody-positive rheumatoid arthritis. J. Clin. Med., 2022, Vol. 11, no. 9, 2341. doi:10.3390/jcm11092341; Fang Q., Zhou C., Nandakumar K.S. Molecular and cellular pathways contributing to joint damage in rheumatoid arthritis. Mediators Inflamm., 2020, Vol. 2020, 3830212. doi:10.1155/2020/3830212.; Jung Y.K., Kang Y.M., Han S. Osteoclasts in the inflammatory arthritis: implications for pathologic osteolysis. Immune Netw., 2019, Vol. 19, no. 1, e2. doi:10.4110/in.2019.19.e2.; Klose-Jensen R., Tse J.J., Keller K.K., Barnabe C., Burghardt A.J., Finzel S., Tam L.S., Hauge E.M., Stok K.S., Manske S.L. High-resolution peripheral quantitative computed tomography for bone evaluation in inflammatory rheumatic disease. Front. Med., 2020, Vol. 7, 337. doi:10.3389/fmed.2020.00337.; Liu F.J., Xie L.Y., Li H.Z., Cao S.N., Chen Y.Z., Bin-Shi, Wang D.D. Expression of ANGPTL4 in nucleus pulposus tissues is associated with intervertebral disc degeneration. Dis. Markers, 2021, Vol. 2021, 3532716. doi:10.1155/2021/3532716.; Llorente I., García-Castañeda N., Valero C., González-Álvaro I., Castañeda S. Osteoporosis in rheumatoid arthritis: dangerous liaisons. Front. Med. (Lausanne), 2020, Vol. 7, 601618. doi:10.3389/fmed.2020.601618.; Masuko K. Angiopoietin-like 4: A molecular link between insulin resistance and rheumatoid arthritis. J. Orthop. Res., 2017, Vol. 35, no. 5, pp. 939-943.; Olshan D.S., Rader D.J. Angiopoietin-like protein 4: A therapeutic target for triglycerides and coronary disease? J. Clin. Lipidol., 2018, Vol. 12, no. 3, pp. 583-587.; Tomizawa T., Ito H., Murata K., Hashimoto M., Tanaka M., Murakami K., Nishitani K., Azukizawa M., Okahata A., D o i K., Saito M., Furu M., Hamaguchi M., Mimori T., Matsuda S. Distinct biomarkers for different bones in osteoporosis with rheumatoid arthritis. Arthritis Res. Ther., 2019, Vol. 21, no. 1, 174. doi:10.1186/s13075-019-1956-1.; Wysham K.D., Baker J.F., Shoback D.M. Osteoporosis and fractures in rheumatoid arthritis. Curr. Opin. Rheumatol., 2021, Vol. 33, pp. 270-276.; Yu S.F., Chen J.F., Chen Y.C., Wang Y.W., Hsu C.Y., Lai H.M., He H.R., Ko C.H., Chiu W.C., Cheng T.T. The impact of seropositivity on systemic bone loss in rheumatoid arthritis-a 3-year interim analysis of a longitudinal observational cohort study. Front. Med. (Lausanne), 2022, Vol. 9, 885801. doi:10.3389/fmed.2022.885801.; Zeng T., Tan L., Yu J., Wu Y. High density lipoprotein in rheumatoid arthritis: emerging role in predicting inflammation level and osteoporosis occurrence. Scand. J. Clin. Lab. Invest., 2020, Vol. 80, no. 5, pp. 375-380.; https://www.mimmun.ru/mimmun/article/view/2862